Clinical trial
The Effect of Glutamine on Reducing Pulmonary Arterial Pressure in Non-transfusion-dependent Thalassemia Patients: a Single Blind Randomized Clinical Trial
NCT07210450 is registered in ClinicalTrials.gov with Mazandaran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Glutamine on Reducing Pulmonary Arterial Pressure in Non-transfusion-dependent Thalassemia Patients: a Single Blind Randomized Clinical Trial
- Lead sponsor
- Mazandaran University of Medical Sciences
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 15, 2023
- Completion date
- September 27, 2025
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-transfusion dependent thalassemia, pulmonary artery pressure, thalassemia